XML 58 R43.htm IDEA: XBRL DOCUMENT v3.25.2
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value at Issuance Date and on Recurring Basis

The following tables present the fair value hierarchy for assets and liabilities that are measured at fair value at issuance date and on a recurring basis and indicate the level within the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value (in thousands):

 

Fair Value Measurement as of December 31, 2024

 

 

Total
Carrying
Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

11,992

 

 

$

11,992

 

 

$

 

 

$

 

Total assets

 

$

11,992

 

 

$

11,992

 

 

$

 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Legacy Allurion Common Stock Warrant Liabilities

 

$

41

 

 

$

 

 

$

 

 

$

41

 

Public Warrants

 

 

396

 

 

 

396

 

 

 

 

 

 

 

Public Offering Warrants

 

 

3,630

 

 

 

 

 

 

 

 

 

3,630

 

Private Placement Warrants

 

 

500

 

 

 

 

 

 

 

 

 

500

 

Revenue Interest Financing

 

 

49,200

 

 

 

 

 

 

 

 

 

49,200

 

Earn-out Liability

 

 

1,090

 

 

 

 

 

 

 

 

 

1,090

 

RTW Convertible Notes

 

 

35,710

 

 

 

 

 

 

 

 

 

35,710

 

Success Fee Derivative Liability

 

 

14

 

 

 

 

 

 

 

 

 

14

 

Total Liabilities

 

$

90,581

 

 

$

396

 

 

$

 

 

$

90,185

 

 

Fair Value Measurement as of December 31, 2023

 

 

 

Total
Carrying
Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

30,582

 

 

$

30,582

 

 

$

 

 

$

 

Total assets

 

$

30,582

 

 

$

30,582

 

 

$

 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Legacy Allurion Common Stock Warrant Liability

 

$

821

 

 

$

 

 

$

 

 

$

821

 

Public Warrants

 

 

5,943

 

 

 

5,943

 

 

 

 

 

 

 

Revenue Interest Financing

 

 

36,200

 

 

 

 

 

 

 

 

 

36,200

 

PIPE Conversion Option (Restated)

 

 

6,410

 

 

 

 

 

 

 

 

 

6,410

 

Earn-out Liability

 

 

23,990

 

 

 

 

 

 

 

 

 

23,990

 

Term Loan Derivative Liability

 

 

1,895

 

 

 

 

 

 

 

 

 

1,895

 

Success Fee Derivative Liability

 

 

14

 

 

 

 

 

 

 

 

 

14

 

Total Liabilities

 

$

75,273

 

 

$

5,943

 

 

$

 

 

$

69,330

 

Schedule of Assumptions used in Pricing Model

The Company has classified the Legacy Allurion Common Stock Warrants, Public Offering Warrants (defined below), and Private Placement Warrants (defined below) within Level 3 of the hierarchy as the fair value is derived using the Black-Scholes option pricing model, which uses a combination of observable (Level 2) and unobservable (level 3) inputs. See table below for the

assumptions used in the pricing model of the Legacy Allurion Common Stock Warrants, Public Offering Warrants, and Private Placement Warrants:

 

 

Measurement
Date

 

Interest
Rate

 

Exercise
Price

 

 

Estimated Fair Value of Underlying Share Price

 

 

Expected
Volatility

 

Expected
Life
(Years)

 

Legacy Allurion Series C Preferred Stock warrants (as converted to Common)

 

December 31, 2024

 

4.44%

 

 

168.25

 

 

 

10.75

 

 

90%

 

 

6.25

 

Legacy Allurion Other Common Stock

 

December 31, 2024

 

4.26%

 

 

26.25

 

 

 

10.75

 

 

90%

 

 

2.69

 

Legacy Allurion Series D-1 Preferred Stock
warrants (as converted to Common)

 

December 31, 2024

 

4.44%-4.5%

 

 

303.50

 

 

 

10.75

 

 

90%

 

6.25-7.71

 

Public Offering Warrants

 

December 31, 2024

 

4.35%

 

 

30.00

 

 

 

10.75

 

 

90%

 

 

4.50

 

Private Placement Warrants

 

December 31, 2024

 

4.35%

 

 

30.00

 

 

 

10.75

 

 

90%

 

 

4.50

 

 

 

Measurement
Date

 

Interest
Rate

 

 

Exercise
Price

 

 

Estimated Fair Value of Underlying Share Price

 

 

Expected
Volatility

 

 

Expected
Life
(Years)

 

Legacy Allurion Series C Preferred Stock warrants (as converted to Common)

 

December 31, 2023

 

 

3.88

%

 

$

168.25

 

 

$

93.50

 

 

 

100

%

 

 

7.25

 

Legacy Allurion Other Common Stock

 

December 31, 2023

 

 

3.95

%

 

 

26.25

 

 

 

93.50

 

 

 

100

%

 

 

3.69

 

Legacy Allurion Series D-1 Preferred Stock
warrants (as converted to Common)

 

December 31, 2023

 

 

3.88

%

 

 

303.50

 

 

 

93.50

 

 

 

100

%

 

7.25-8.71

 

Schedule of Changes in Fair Values

The following table reconciles the changes in fair value for the years ended December 31, 2024 and 2023 of the warrant liabilities valued using Level 3 inputs:

 

 

Preferred Stock Warrants (as converted to Common)

 

 

Common Stock Warrants

 

 

Public Offering Warrants

 

 

Private Placement Warrants

 

 

Total

 

Balance – January 1, 2023

 

$

1,777

 

 

$

596

 

 

 

 

 

 

 

 

$

2,373

 

Change in fair value

 

 

(720

)

 

 

172

 

 

 

 

 

 

 

 

 

(548

)

Exercise of warrants

 

 

(75

)

 

 

 

 

 

 

 

 

 

 

 

(75

)

Derecognition of liability to equity

 

 

(340

)

 

 

(589

)

 

 

 

 

 

 

 

 

(929

)

Balance – December 31, 2023

 

$

642

 

 

$

179

 

 

$

 

 

$

 

 

$

821

 

Fair value at issuance

 

$

 

 

$

 

 

$

13,157

 

 

$

1,670

 

 

$

14,827

 

Change in fair value

 

 

(610

)

 

 

(170

)

 

 

(9,527

)

 

 

(1,170

)

 

 

(11,477

)

Balance – December 31, 2024

 

$

32

 

 

$

9

 

 

$

3,630

 

 

$

500

 

 

$

4,171

 

Schedule of Estimated Fair Value was Measured Using a Monte Carlo Simulation Method

The assumptions used in the Black-Scholes option-pricing model are as follows:

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

Expected volatility

 

 

71.2

%

 

 

85.8

%

Risk-free interest rate

 

 

4.4

%

 

 

4.5

%

Expected dividend yield

 

 

%

 

 

%

Expected term (in years)

 

6.1

 

 

 

5.8

 

 

Public Warrants  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Changes in Fair Values

The changes in the fair values of the Success Fee derivative liability, 2023 Convertible Notes, PubCo Additional Shares liability, Base PubCo Shares and Backstop Shares liability, Revenue Interest Financing, PIPE Conversion Option, Earn-out liability, Term Loan Derivative Liability, and RTW Convertible Notes categorized with Level 3 inputs for the years ended December 31, 2024 and 2023 were as follows:

 

 

Success Fee
Derivative Liability

 

 

2023
Convertible
Notes

 

 

Revenue
Interest
Financing

 

 

PIPE
Conversion
Derivative

 

 

Earn-Out
Liability

 

 

Term Loan Derivative Liability

 

 

RTW Convertible Notes

 

 

PubCo
Share
Liability

 

 

Base
PubCo &
Backstop
Share
Liability

 

 

Total

 

Balance – January 1, 2023

 

$

178

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

178

 

Fair value upon issuance

 

 

 

 

 

28,700

 

 

 

40,000

 

 

 

3,340

 

 

 

53,040

 

 

 

1,895

 

 

 

 

 

 

3,370

 

 

 

3,264

 

 

 

133,609

 

Change in fair value (Restated) (1)

 

 

(164

)

 

 

3,751

 

 

 

(2,008

)

 

 

3,070

 

 

 

(29,050

)

 

 

 

 

 

 

 

 

(642

)

 

 

10,106

 

 

 

(14,937

)

Change in fair value - OCI (Restated) (1)

 

 

 

 

 

 

 

 

(700

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(700

)

Repayments of debt

 

 

 

 

 

(10,750

)

 

 

(1,092

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(11,842

)

Derecognition of liability to
   equity

 

 

 

 

 

(21,701

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,728

)

 

 

(13,370

)

 

 

(37,799

)

Balance – December 31, 2023 (Restated)

 

$

14

 

 

$

 

 

$

36,200

 

 

$

6,410

 

 

$

23,990

 

 

$

1,895

 

 

$

 

 

$

 

 

$

 

 

$

68,509

 

Fair value upon issuance

 

 

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

49,100

 

 

 

 

 

 

 

 

 

49,100

 

Change in fair value (Restated) (1)

 

 

 

 

 

 

 

 

4,328

 

 

 

990

 

 

 

(22,900

)

 

 

(1,895

)

 

 

(18,090

)

 

 

 

 

 

 

 

 

(37,567

)

Change in fair value - OCI (Restated) (1)

 

 

 

 

 

 

 

 

4,370

 

 

 

 

 

 

 

 

 

 

 

 

4,700

 

 

 

 

 

 

 

 

 

9,070

 

Exercise of warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of PIPE Conversion Option

 

 

 

 

 

 

 

 

7,400

 

 

 

(7,400

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repayments of debt

 

 

 

 

 

 

 

 

(3,098

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,098

)

Balance – December 31, 2024

 

$

14

 

 

$

 

 

$

49,200

 

 

$

 

 

$

1,090

 

 

$

 

 

$

35,710

 

 

$

 

 

$

 

 

$

86,014

 

(1) As discussed in FN 2, Restatement of Previously Issued Financial Statements, the Company identified an Error in its historical financial statements related to the change in fair value due to instrument specific credit risk for the Revenue Interest Financing and RTW Convertible Notes, as well as a change in fair value of the PIPE Conversion Option. The only restated numbers in the table above relate to the

'Change in fair value' and 'Change in fair value - OCI' for both the Revenue Interest Financing and RTW Convertible Notes, as well as the 'Change in fair value' related to the PIPE Conversion Option.

Earn-Out Liability  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Estimated Fair Value was Measured Using a Monte Carlo Simulation Method The estimated fair value of the earn-out shares was determined using a Monte Carlo Simulation Method using the following assumptions at the following valuation dates:

 

 

December 31, 2024

 

 

December 31, 2023

 

Stock Price

 

10.75

 

 

93.5

 

Risk-free interest rate

 

 

4.3

%

 

 

3.9

%

Expected term (in years)

 

3.6

 

 

4.6

 

Expected volatility

 

 

109.0

%

 

 

87.0

%

 

Revenue Interest Financing and PIPE Conversion Option  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Estimated Fair Value was Measured Using a Monte Carlo Simulation Method

The fair value of the PIPE Conversion Option was accounted for as a derivative under ASC 815. The instrument was measured using a Monte Carlo Simulation Method using the number of shares convertible of 42,614 and the below assumptions. Upon the exercise of the PIPE Conversion Option and resulting New RIFA on October 30, 2024, the PIPE Conversion Option was reclassified as an additional to the Revenue Interest Financing liability, and as such there is no PIPE Conversion Option liability as of December 31, 2024.

 

 

December 31, 2023

Stock Price

 

93.5

Risk-free interest rate

 

4.46%

Expected term (in years)

 

1.6

Expected volatility

 

82.5%

RTW Convertible Notes  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Estimated Fair Value was Measured Using a Monte Carlo Simulation Method The fair value was measured using the $48.0 million principal amount of the RTW Convertible Notes and the following assumptions:

 

December 31, 2024

 

Stock Price

 

10.75

 

Risk-free interest rate

 

 

4.4

%

Expected term (in years)

 

6.3

 

Expected volatility

 

 

90.0

%